casimiropt / Shutterstock.com
13 August 2019Big PharmaSaman Javed
Allergan says rivals using trade secrets disclosed by USITC order
Allergan has filed a motion asking for its “trade secrets” to be removed from evidence in a dispute over its wrinkle treatment, Botox.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Biotechnology
14 July 2020 The US International Trade Commission (USITC) will take another look at whether German orthopedics company Zimmer Biomet violated the IP rights of medical technology company Heraeus, it announced yesterday, Monday 13 July.
Americas
11 September 2020 Cannabinoid maker Lavvan has filed a $881 million trade secrets lawsuit against pharmaceutical company Amyris.
Big Pharma
18 December 2020 The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.
Editor's picks
Editor's picks
Biotechnology
14 July 2020 The US International Trade Commission (USITC) will take another look at whether German orthopedics company Zimmer Biomet violated the IP rights of medical technology company Heraeus, it announced yesterday, Monday 13 July.
Americas
11 September 2020 Cannabinoid maker Lavvan has filed a $881 million trade secrets lawsuit against pharmaceutical company Amyris.
Big Pharma
18 December 2020 The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.
Biotechnology
14 July 2020 The US International Trade Commission (USITC) will take another look at whether German orthopedics company Zimmer Biomet violated the IP rights of medical technology company Heraeus, it announced yesterday, Monday 13 July.
Americas
11 September 2020 Cannabinoid maker Lavvan has filed a $881 million trade secrets lawsuit against pharmaceutical company Amyris.
Big Pharma
18 December 2020 The US International Trade Commission has sided in favour of AbbVie/Allergan, which argued that a rival should be prevented from importing a low-cost version of its Botox treatment into the US for 21 months, because it had stolen trade secrets.